BackAbattis Bioceuticals Overview

Abattis Bioceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ATTBF.

Quarterly EBIT

-$470.10K
↓ 106.33% YoY

As of Sep 30, 2019

Annual EBIT (TTM)

-$3.91M
↑ 77.48% YoY

Trailing 12 months ending Sep 30, 2019

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin